Reyes ZYI, Sanabria NJG, Marrero FR

Language: Spanish
References: 20
Page: 753-766
PDF size: 200.21 Kb.

ABSTRACT

Introduction: there is lack of knowledge about the impact of the Cervical Uterine Cancer Early Screening Program in the health area of Pedro Borrás Astorga University Outpatient Polyclinic.
Objective: to evaluate the impact of the Cervical Uterine Cancer Early Screening Program in the health area of Pedro Borrás Astorga University Outpatient Polyclinic, Pinar del Río, years 2004-2011.
Material and method: an observation, retrospective and descriptive research was carried out, using the automatized database of the Provincial Medical Office of Cervical Pathology, from the Provincial Records of Cancer and the Province Mortality Records and the health area of Pedro Borrás Astorga University Outpatient Polyclinic in the considered period, and the Province Office of Statistics for a particular year. The annual incidence rate of lesions was determined, specifically by severity and age groups, and also the mortality rate for this cause.
Results: the highest number of frequencies of cervical lesions diagnosed was detected in the year 2010 (72 women), the highest frequency corresponded to cervical intraepithelial neoplasias in stage I (low stage) (203 CIN I). The higher the lesions' degree of severity, the lower the frequencies, and thus the annual incidence rates. Mortality for cervical uterine cancer was acarce.
Conclusions: increase in the number of premalignant lesions and the annual incidence rates. Increase in the number of premalignant lesions in young women (under 35 years of age) in comparison to those at age 35 or older. Increase in the number of in situ carcinoma within the time period. There was a decreasing tendency in the cases of invading cervical uterine carcinomata and the mortality for cervical uterine cancer.

REFERENCES

1. Ferlay J, Shin HR, Bray F, Norman D, Matehrs C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127(12): 2893-917.

2. Sahasrabuddhe VV, Parham GP, Mwanahamuntu MH, Vermund SH. Cervical cancer prevention in low-and middle-income countries: feasible, affordable, essential. Cancer Prevention Research. Dec 12 2011; 5: 12-17.

3. Forouzanfar MH, Foreman KJ, Delossantos AM, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 2011; 378(9801):1461-84.

4. Colombia. CIES-Fundación Santa Fe de Bogotá. Gráfica-Mortalidad por cáncer del cuello uterino CIES-Fundación Santa Fe de Bogotá. 2012.

5. Cabezas Cruz E, Camacho Canino T, Santana Martínez A, Borrajero Martínez I, Aguilar Vela de Oro F, Romero Pérez T, et al. Programa Nacional de Diagnóstico precoz del Cáncer Cervicouterino. La Habana: Editorial Ciencias Médicas; 2000.

6. Galán Y, Fernández L, Torres P, García M. Trends in Cuba´s Cancer Incidence (1990 to 2003) and mortality (1990 to 2007). MEDICC Review, Summer. 2009; 11(3): 19-26.

7. Richart RM. Cervical intraepithelial neoplasia. Pathol Ann 1973; 8:301-28.

8. Solomon D, Davey D, Kurman R et al. Forum Group Members, Bethesda 2001 Workshop. The 2001 Bethesda System; terminology for reporting results of cervical cytology. JAMA. 2002; 287; 2114-9.

9. ACOG Committee on Practice Bulletins-Gynecology. ACOG Practice Bulletin no. 109: Cervical cytology screening. Obstet Gynecol. 2009 Dec; 114 (6):1409-20.

10. Yasmeen S, Romano PS, Pettinger M, Johnson SR, Hubbell FA, Lane DS, Hendrix SL. Incidence of cervical cytological abnormalities with aging in the women's health initiative: a randomized controlled trial. Obstet Gynecol 2006 Aug; 108(2):410-9.

11. Siebers AG, Klinkhamer PJ, Grefte JM, Massuger LF, Vedder JE, Beijers-Broos A, Bulten J, Arbyn M. Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial. JAMA. 2009 Oct 28; 302(16):1757-64.

12. Andrae B, Andersson TM, Lambert PC, Kemetli L, Silfverdal L et al. Screening and cervical cancer cure: population based cohort study. BMJ. 2012 Mar 1; 344: e900.

13. Organización Panamericana de la Salud. Cáncer cervicouterino[Internet]. OPS; 2013.

14. Benard VB, Coughlin SS, Thompson T, Richardson LC. Cervical cancer incidence in the United States by area of residence, 1998-2001. Obstet Gynecol. 2007 Sep; 110(3):681-6.

15. Kohler BA, Ward E, McCarthy BJ, Schymura MJ, Ries LA, Eheman C, Jemal A, Anderson RN, Ajani UA, Edwards BK. Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst 2011 May 4; 103(9):714-36.

16. Sanabria Negrín JG, Abreu Mérida M, Salvueiro VE. Tendencias del cáncer cervicouterino. Pinar del Río 1988-2004. VII Congreso Latinoamericano Virtual de Anatomía Patológica. España 2005.

17. Ramírez Valle M, Sanabria Negrín JG, Salgueiro Medina VE. Evaluación del programa de detección precoz de cáncer cervicouterino en Consolación del Sur. Rev Ciencias Médicas. 2013 Feb 17(1): 36-48.

18. Cuba. Ministerio de Salud Pública. Anuario Estadístico 2011. La Habana: MINSAP.

19. Ma LT, Campbell GA, Richardson G, Schnadig VJ. Should high-risk adolescents have Papanicolaou tests? Cancer Cytopathol 2013; 121(8): 432-439.

20. Sanabria Negrín JG, Salgueiro Medina VE, Abreu Mérida MB, Vólquez C. Incremento de la detección de lesiones cervicales mediante inspección visual. Puerto Esperanza. 2008. Rev Ciencias Médicas. 2011 Sep; 15(3): 81-98.